Orca Bio

Associate Director, Market Development - East

Remote

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, HealthcareIndustries

Requirements

Candidates should have extensive experience in hematology/oncology and allogeneic bone marrow transplant sales or marketing, with field-based marketing experience preferred. They should possess a fluency in leukemia and/or bone marrow transplant clinical areas, academic center account experience, and launch experience. A BA/BS degree in a related discipline is required, with an advanced degree (MA/MBA/PharmD) being preferred. The candidate must be able to travel approximately 50% of the time, including overnight travel.

Responsibilities

The Associate Director, Market Development, East will design and execute KOL engagement strategies, manage HCP-facing responsibility for the Marketing team, leverage KOL insights to inform Brand strategy, manage regional marketing budget, identify and recruit KOL speakers, develop promotional speaker training, contribute to COE onboarding, create Brand strategy, develop Brand tactics, identify KOL champions, contribute to scientific education, integrate with regional cross-functional teams, interact with the Sales Force, and comply with all applicable laws and regulations. They will also be responsible for congress strategy and execution, exhibit staffing, strategic sponsorship management, advisory board content and execution, and content creation.

Skills

KOL engagement
relationship development
scientific feedback
product feedback
marketing strategy
brand messaging
speaker training
COE profiling
cross-functional collaboration

Orca Bio

Develops and commercializes cell therapies

About Orca Bio

Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company works to enhance these therapies, aiming to make them safer and more effective for patients. Orca Bio's products are primarily used by healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to improve patient outcomes through advanced cell therapies, addressing conditions that currently have limited treatment options.

Key Metrics

Menlo Park, CaliforniaHeadquarters
2016Year Founded
$186.8MTotal Funding
SERIES_DCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Unlimited Paid Time Off
401(k) Retirement Plan
Parental Leave

Risks

Emerging competition from BlueRock Therapeutics in stem cell therapies.
Aspen Neuroscience's advancements in personalized stem cell therapies pose a threat.
Competitors' focus on iPSC-derived therapies may overshadow Orca Bio's offerings.

Differentiation

Orca Bio focuses on high-precision cell therapies for cancer and autoimmune diseases.
Their lead product, Orca-T, shows promising relapse-free survival rates in clinical trials.
Orca Bio's therapies aim to replace diseased blood and immune systems with healthy ones.

Upsides

Orca-T demonstrated 87% relapse-free survival in a Phase 1b/2 trial.
FDA's expedited approval pathways could accelerate Orca Bio's market entry.
Advancements in gene editing enhance the efficacy of Orca Bio's cell therapies.

Land your dream remote job 3x faster with AI